Sonic Healthcare (SHL) Stock Price, News & Analysis

Company Overview

Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services. The company operates in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and internationally. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 1.46 million shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 3.89%
• Price Target: N/A
• Consensus Rating: N/A

SHL Stock Analysis - Frequently Asked Questions

How were Sonic Healthcare's earnings last quarter?

Sonic Healthcare Limited (ASX:SHL) released its quarterly earnings results on Wednesday, February, 20th. The health services provider reported $0.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.56 by $0.04. Sonic Healthcare had a trailing twelve-month return on equity of 6.80% and a net margin of 5.70%.

What other stocks do shareholders of Sonic Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Sonic Healthcare investors own include CSL (CSL), BHP Group (BHP), Commonwealth Bank of Australia (CBA), Contact Energy (CEN), Fortescue (FMG), Meta Platforms (META) and Mineral Resources (MIN).

Company Calendar

• Last Earnings: 2/20/2019
• Ex-Dividend for 9/18 Dividend: 9/03/2024
• Dividend Payable: 9/18/2024
• Today: 12/04/2024

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Diagnostics & Research
• Sub-Industry: N/A
• Current Symbol: ASX:SHL
• CUSIP: N/A
• CIK: N/A
• Web: www.sonichealthcare.com
• Phone: +61-2-98555444
• Fax: N/A
• Employees: 41,000
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): A$1.07
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: -1.19
• Net Income: $511.09 million
• Net Margins: 5.70%
• Pretax Margin: N/A
• Return on Equity: 6.80%
• Return on Assets: 3.88%

Debt

• Debt-to-Equity Ratio: 55.92
• Current Ratio: 1.01
• Quick Ratio: 0.96

Sales & Book Value

• Annual Sales: $8.97 billion
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 28.91
• Book Value: A$16.49 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 480,400,000
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 0.51